Published in Gene Therapy Weekly, December 1st, 2005
"A crylC gene, whose product is active against Spodoptera exigua, was introduced into wildtype B. thuringiensis kurstaki strain YBT1520 using an integrative and thermosensitive vector, pBMB-FLCE, which was developed based on B. thuringiensis transposon Tn4430 harboring a tnpl-tnpA gene."
"With the mediation of Tnpl-TnpA, the cry1C gene was integrated into the chromosome of the host strain," wrote C.Y. Yue and colleagues,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-12-01)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.